Krystal Biotech (KRYS) Change in Inventory (2023 - 2026)

Krystal Biotech (KRYS) has 4 years of Change in Inventory data on file, last reported at $243000.0 in Q1 2026.

• For the quarter ending Q1 2026, Change in Inventory fell 82.58% year-over-year to $243000.0; the trailing twelve-month figure through Mar 2026 stood at $5.1 million (down 53.6% YoY), and the FY2025 full-year result was $6.3 million, down 47.21% from the prior year.
• Change in Inventory eased to $243000.0 in Q1 2026, from $1.1 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $6.5 million in Q4 2024 to a low of -$880000.0 in Q2 2025.
• A 4-year average of $1.9 million and a median of $1.2 million in 2025 frame the typical range for Change in Inventory.
• Peak annual rise in Change in Inventory reached 1225.41% in 2024, while the deepest fall reached 158.5% in 2024.
• Tracing KRYS's Change in Inventory over 4 years: stood at $492000.0 in 2023, then jumped by 1225.41% to $6.5 million in 2024, then sank by 83.78% to $1.1 million in 2025, then slumped by 77.03% to $243000.0 in 2026.
• Business Quant data shows KRYS's Change in Inventory at $243000.0 in Q1 2026, $1.1 million in Q4 2025, and $4.7 million in Q3 2025.